AI is changing hepatology, but using it effectively takes more than just the technology. 🤖 Explore sessions on integrating AI into clinical practice, improving patient care, and navigating its use in training. Save this post and add these sessions to your #TLM26 schedule. #Hepatology #AI #LiverCare

🔥HOT TOPIC 📙@LTxJournal Reducing deaths on the liver transplant waitlist requires looking beyond the numbers. This article highlights how risk prediction, organ utilization, center practices, and equity can help improve patient care and inform transplant policy. Read more ➡️ bit.ly/4h6HofF

ℹ️ Two new resources advancing care in #pediatric #livertransplantation from AASLD publications! AASLD, @AST_info, and @NASPGHAN have developed evidence-based practice guidelines to support clinicians and improve care across the #pediatriclivertransplant journey. 📗 Explore the candidate evaluation practice guideline in @HEP_Journal: bit.ly/4d2DMJ8 📙 Explore the posttransplant management practice guideline in @LTxJournal: bit.ly/4AATVjd

🔥 HOT TOPIC 📷@HepCommJournal Current testing strategies may be missing patients with fibrotic #MASLD. This study highlights potential limitations of sequential FIB-4 testing and how approaches like ELF testing could improve detection. Read more: ovid.com/jnls/hepcomm/fullte…

This #HispanicHeritageMonth, join AASLD for an important conversation on advancing liver health in the Latino community. Register now for the webinar to hear from experts Monica Tincopa, MD, Msc @MonicaTincopa and Blanca Lizaola-Mayo, MD @Blankmd22 as they explore unmet needs, #healthdisparities, and opportunities to improve the prevention, diagnosis and management of #MASLD and #MASH in Latino communities. 🔗 Register to attend: bit.ly/4jkG9uA

From networking receptions to community events, #TLM26 offers countless ways to connect beyond the educational sessions. Explore this year's special events and start planning your time in Denver! bit.ly/4gG1KuO #AASLD #HepatologyCommunity

🔥 HOT TOPIC 📗 @HEP_Journal A new path toward functional cure for chronic #hepatitisB is taking shape. This randomized trial explores a two-phase strategy combining nucleos(t)ide withdrawal with pegylated interferon, offering insights that could help inform future treatment strategies for long-term treated patients. Read the article in #HEPATOLOGY: bit.ly/3VLgxgH

ICYMI: AASLD joined leading GI societies in supporting annual #flu and #COVID19 vaccination to help protect patients with digestive and #liverdiseases from vaccine-preventable illness. Read the joint statement and learn more on the AASLD Policy Communications webpage: aasld.org/policy-communicati…. @AmCollegeGastro @AGA_Gastro @ASGEendoscopy @NASPGHAN @ImproveCareNow @CrohnsColitisFn

Co-Editors @ebtapper and Carmen Chak-Lui Wong share exciting science from the September issue of @HepCommJournal, including metabolic syndrome in ALD, MRE liver stiffness, MASLD-HCC, gene therapy for PFIC2, and more. Watch below and view the latest issue here: journals.lww.com/hepcomm/toc… piped.video/_iJR_FD1jyQ

What have you completed on your LiverLearning® checklist? Take your learning on-the-go with activities that help you stay current in your journey to lead in liver care. ☐ Unmasking MASH and MASLD: An estimated 41.4% or 122 American adults are predicted to have MASLD by 2050. Strengthen your understanding of the clinical significance of MASLD/MASH: bit.ly/44CcWn2 ☐ Medscape: Targeting Viral Hepatitis: Nearly one third of people with hepatitis C are unaware of their infection. Learn how to close screening gaps. bit.ly/49vlrCK ☐ Explore other offerings: Practice Guidelines, webinars, conferences, and more are available to you on LiverLearning. bit.ly/4otNHtV

New research highlights the growing global impact of metabolic dysfunction-associated steatotic liver disease (MASLD), with an estimated 1.3 billion people worldwide living with MASLD in 2023 and projections reaching 1.8 billion by 2050. These findings reinforce the need for continued collaboration across the liver community to advance prevention, diagnosis, and treatment strategies. Read the full article here: bit.ly/4gP2YnE #TLM26 #Hepatology #MASLD

🔬A special issue dedicated entirely to #livercancer is now online in @HEP_Journal! The October special issue brings together the latest research and clinical insights advancing our understanding and care of liver cancer. ▶️Watch Associate Editors Jordi Bruix, MD, PhD @bruixjand and @SumeraIlyasMD, introduce the issue and highlight what readers can expect from this curated collection. 📗Explore the special issue: journals.lww.com/hep/toc/cur…

#AASLD members, have you voted yet? Make your voice heard and help select the leaders who will help shape AASLD’s future. Eligible members received an email from Election Runner with a unique voter ID/key and direct ballot link. ✅ Cast your vote by Oct. 1 at 11:59 p.m. EDT.

Meet Dr. Gene Im, a transplant hepatologist and leader in the field of alcohol-associated liver disease (ALD). As Director of the Alcohol-associated Liver Disease Program at Columbia University and Chair of the AASLD Alcohol SIG, Dr. Im brings extensive clinical and research expertise to #TLM26. 👉 Explore his featured sessions on ALD and discover insights you can take back to your practice. bit.ly/4xvhQP7 #AASLD #Hepatology #ALD

Take the next step in your #hepatology career. Apply to become an #AASLD Fellow or Associate Fellow and earn recognition for your professional achievements, contributions and leadership in the field. Applications are due Dec. 15: aasld.org/fellows-program

🚨 Late-breaking abstract submissions are now open for #TLM26! Showcase your research, connect with global liver leaders, and contribute to the latest advancements in liver disease prevention, diagnosis, and treatment. 🔗 Ready to submit? Review the submission criteria to see if your work qualifies, then bring your research to the forefront of the liver community. bit.ly/4cAe7Yn #Hepatology #MedicalEducation

Address the awareness gap in routine pediatric hepatology care by registering for this on-the-go Sept. 22 webinar. Faculty experts Valerie McLin, MD, Cristina Padros Fornieles, MD, and Sharon DeMorrow, PhD will discuss neurocognitive involvement across the clinical spectrum, including its assessment, and management. Save your seat at bit.ly/4h7jrU2.

🚨You have two weeks left to finish your application for the 2027 AGA-AASLD Academic Skills Workshop. Don’t miss engaging sessions, like ‘What To Look for in a Mentor’ and dedicated faculty that can help you create a successful academic medicine career. Applications due Monday, Sept. 28, finish your application at bit.ly/4yD57tL

How do you individualize treatment for patients with high-risk #HCC? Explore the new CME activity by @mlieducation on evolving frontline immune checkpoint inhibitor-based therapies, with a focus on #liver reserve, tumor burden, mortality risk, and patient-specific factors. 🔗 bit.ly/4xcSqEI

Congratulations to our own Dr Kusnik on being named for this award!🥇 We are so excited to have you staying on as faculty next year! ✨ @AKusnik @AASLDFoundation @AASLDtweets